0 CHECKOUT

Retinoblastoma - Pipeline Review, H1 2015

  • ID: 3275720
  • May 2015
  • 57 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • BioLineRx, Ltd.
  • Cellceutix Corporation
  • Icon Bioscience, Inc.
  • Neotropix, Inc.
  • Recombio S.L
  • MORE

Retinoblastoma - Pipeline Review, H1 2015

Summary

The‘Retinoblastoma - Pipeline Review, H1 2015’, provides an overview of the Retinoblastoma’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Retinoblastoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinoblastoma and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • BioLineRx, Ltd.
  • Cellceutix Corporation
  • Icon Bioscience, Inc.
  • Neotropix, Inc.
  • Recombio S.L
  • MORE

List of Tables

List of Figures

Introduction

Report Coverage

Retinoblastoma Overview

Therapeutics Development

Pipeline Products for Retinoblastoma - Overview

Pipeline Products for Retinoblastoma - Comparative Analysis

Retinoblastoma - Therapeutics under Development by Companies

Retinoblastoma - Therapeutics under Investigation by Universities/Institutes

Retinoblastoma - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Retinoblastoma - Products under Development by Companies

Retinoblastoma - Products under Investigation by Universities/Institutes

Retinoblastoma - Companies Involved in Therapeutics Development

BioLineRx, Ltd.

Cellceutix Corporation

Icon Bioscience, Inc.

Neotropix, Inc.

Recombio S.L

RXi Pharmaceuticals Corporation

Retinoblastoma - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

BL-8040 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Kevetrin - Drug Profile

Product Description

Mechanism of Action

R&D Progress

melphalan - Drug Profile

Product Description

Mechanism of Action

R&D Progress

NTX-010 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

nutlin-3 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

racotumomab - Drug Profile

Product Description

Mechanism of Action

R&D Progress

RNAi Oligonucleotide for Retinoblastoma - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Retinoblastoma - Recent Pipeline Updates

Retinoblastoma - Dormant Projects

Retinoblastoma - Product Development Milestones

Featured News & Press Releases

Mar 08, 2013: Cellceutix Announces Positive Preclinical Trial Data Of Kevetrin In Retinoblastoma

Jan 03, 2013: Icon's Melphalan Intraocular Injection Receives US Orphan Drug Designation For Treatment Of Retinoblastoma

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Number of Products under Development for Retinoblastoma, H1 2015

Number of Products under Development for Retinoblastoma - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Number of Products under Investigation by Universities/Institutes, H1 2015

Comparative Analysis by Clinical Stage Development, H1 2015

Comparative Analysis by Early Stage Development, H1 2015

Products under Development by Companies, H1 2015

Products under Investigation by Universities/Institutes, H1 2015

Retinoblastoma - Pipeline by BioLineRx, Ltd., H1 2015

Retinoblastoma - Pipeline by Cellceutix Corporation, H1 2015

Retinoblastoma - Pipeline by Icon Bioscience, Inc., H1 2015

Retinoblastoma - Pipeline by Neotropix, Inc., H1 2015

Retinoblastoma - Pipeline by Recombio S.L, H1 2015

Retinoblastoma - Pipeline by RXi Pharmaceuticals Corporation, H1 2015

Assessment by Monotherapy Products, H1 2015

Number of Products by Stage and Target, H1 2015

Number of Products by Stage and Mechanism of Action, H1 2015

Number of Products by Stage and Route of Administration, H1 2015

Number of Products by Stage and Molecule Type, H1 2015

Retinoblastoma Therapeutics - Recent Pipeline Updates, H1 2015

Retinoblastoma - Dormant Projects, H1 2015

List of Figures:

Number of Products under Development for Retinoblastoma, H1 2015

Number of Products under Development for Retinoblastoma - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Comparative Analysis by Early Stage Products, H1 2015

Assessment by Monotherapy Products, H1 2015

Number of Products by Top 10 Targets, H1 2015

Number of Products by Stage and Top 10 Targets, H1 2015

Number of Products by Top 10 Mechanism of Actions, H1 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015

Number of Products by Top 10 Routes of Administration, H1 2015

Number of Products by Stage and Top 10 Routes of Administration, H1 2015

Number of Products by Top 10 Molecule Types, H1 2015

Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

- BioLineRx, Ltd.
- Cellceutix Corporation
- Icon Bioscience, Inc.
- Neotropix, Inc.
- Recombio S.L
- RXi Pharmaceuticals Corporation

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Photocure ASA
  • Roche Diagnostics Ltd.
  • Abbott Laboratories Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Becton, Dickinson and Company (BD)